Transcriptional and Functional Analysis Shows Sodium Houttuyfonate-Mediated Inhibition of Autolysis in Staphylococcus aureus

Guoxing Liu; Hua Xiang; Xudong Tang; Kaiyu Zhang; Xiuping Wu; Xuelin Wang; Na Guo; Haihua Feng; Guangming Wang; Lihui Liu; Qiyun Shi; Fengge Shen; Mingxun Xing; Peng Yuan; Mingyuan Liu; Lu Yu
October 2011
Molecules;Oct2011, Vol. 16 Issue 10, p8848
Academic Journal
Sodium houttuyfonate (SH), an addition compound of sodium bisulfite and houttuynin, showed in vitro antibacterial activity against 21 Staphylococcus aureus (S. aureus) strains grown in planktonic cultures. Microarray results showed decreased levels of autolysin atl, sle1, cidA and lytN transcripts in the SH-treated strain as compared to the control strain, consistent with the induction of the autolytic repressors lrgAB and sarA and with the downregulation of the positive regulators agrA and RNAIII. Triton X-100-induced autolysis was significantly decreased by SH in S. aureus ATCC 25923, and quantitative bacteriolytic assays and zymographic analysis demonstrated SH-mediated reduction of extracellular murein hydrolase activity in these cells. Anti-biofilm assay showed that SH is poorly active against S. aureus grown in biofilm cultures, whereas SH diminished the amounts of extracellular DNA (eDNA) of S. aureus in a dose-dependent manner, which suggested that SH may impede biofilm formation by reducing the expression of cidA to inhibit autolysis and eDNA release in the early phase. Some of the microarray results were confirmed by real-time RT-PCR.


Related Articles

  • Potential of Bacteriophages and Their Lysins in the Treatment of MRSA. Borysowski, Jan; Łobocka, Małgorzata; Międzybrodzki, Ryszard; Weber-Dąbrowska, Beata; Gólrski, Andrzej // BioDrugs;2011, Vol. 25 Issue 6, p347 

    Bacteriophages (phages) are viruses that specifically infect and kill bacteria. Lysins are enzymes of bacteriophage origin that cleave covalent bonds in peptidoglycan, thereby inducing rapid lysis of a bacterial cell. As potential antibacterial agents, phages and lysins have some important...

  • Development of Reduced Vancomycin Susceptibility in Methicillin-Susceptible Staphylococcus aureus. Pillai, Satish K.; Wennersten, Christine; Venkataraman, Lata; Eliopoulos, George M.; Moellering Jr., Robert C.; Karchmer, Adolf W. // Clinical Infectious Diseases;10/15/2009, Vol. 49 Issue 8, p1169 

    Background. Most cases of reduced vancomycin susceptibility in Staphylococcus aureus reported in the literature have been in methicillin-resistant strains. We report the development of reduced vancomycin susceptibility in a series of clonally related, methicillin-susceptible S. aureus (MSSA)...

  • Telavancin: A Novel Lipoglycopeptide. Saravolatz, Louis D.; Stein, Gary E.; Johnson, Leonard B. // Clinical Infectious Diseases;12/15/2009, Vol. 49 Issue 12, p1908 

    Telavancin, a derivative of vancomycin, is a lipoglycopeptide antibiotic that has been shown to be effective for the treatment of complicated skin and skin-structure infections. It has also been effective in the treatment of gram-positive pneumonia. This antibiotic has a dual mechanism of action...

  • Structural insight into the binding mode between the targeting domain of ALE-1 (92AA) and pentaglycine of peptidoglycan. Hideki Hirakawa; Hidenori Akita; Tamaki Fujiwara; Motoyuki Sugai; Satoru Kuhara // PEDS: Protein Engineering, Design & Selection;Jul2009, Vol. 22 Issue 7, p385 

    ALE-1 is a glycylglycine endopeptidase that selectively targets and lyses Staphylococcus aureus, and is expected to be a next generation antibacterial agent because of its substrate specificity to pathogenic bacteria. It has a central catalytic domain and a targeting domain called 92AA. 92AA has...

  • Antibacterial drugs: New antibiotics on the horizon? Crunkhorn, Sarah // Nature Reviews Drug Discovery;Feb2013, Vol. 12 Issue 2, p99 

    The article discusses two studies which present strategies for combating Staphylococcus aureus which is responsible for various diseases. One study has examined potential leukotoxin receptors in an attempt to identify novel therapeutic targets. Meanwhile, another study has sought to inhibit the...

  • Characterization of essential enolase in Staphylococcus aureus. Xuping Yu; Li Zheng; Junshu Yang; Ting Lei; Yinduo Ji // World Journal of Microbiology & Biotechnology;Apr2011, Vol. 27 Issue 4, p897 

    In this study, we characterized the essentiality of enolase for growth of Staphylococcus aureus in vitro by using a TetR-regulated antisense RNA expression technology. The induced enolase antisense RNA dramatically decreased the production of enolase, which in turn inhibited the growth of S....

  • Alert on risk of MRSA following topical antibacterial use.  // Pulse;4/7/2010, Vol. 70 Issue 11, p4 

    The article reports on the precaution of general practitioners (GPs) on the use of tropical antibacterials for skin infections which may lead to serious methicillin resistant staphylococcus aureus (MRSA) infections.

  • Children in Hospitals. Monaco, John E. // Pediatrics for Parents;2006, Vol. 22 Issue 8, p6 

    The article offers information about the infections brought about by the Methicillin resistant Staphylococcus aureus bacteria. This bacteria, which have been around for ages but still increasingly develop resistant strains, cause skin and soft tissue infections. These conditions have reached...

  • Resistance in 18 steps. Mullard, Asher // Nature Reviews Microbiology;Jul2007, Vol. 5 Issue 7, p474 

    This article presents a research on meticillin-resistant Staphylococcus aureus. It reports that vancomycin is the newest drug of choice for the treatment of meticillin-resistant Staphylococcus aureus. However, it can develop resistance to vancomycin during a course of treatment, which can leave...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics